WPP Plc (LON:WPP) announced that its wholly owned global digital agency, Wunderman, is acquiring Gorilla, Inc. an award-winning e-commerce specialist based in the U.S. Gorilla Group’s revenues were US$40 million..
Rainbow Rare Earth Ltd (LON:RBW) mining company, today announced it has entered into a Cooperation Agreement with TechMet Limited to fund a Definitive Feasibility Study for downstream rare earth separation...
Solo Oil Plc (LON:SOLO) today announced board changes. Alastair Ferguson has now taken over as Non-Executive Chairman and Neil Ritson has retired as Executive Chairman and as a director of..
SAGA Plc (LON:SAGA) further to the announcement made on 28 March 2018, the UK’s specialist in products and services for life after 50, is now able to confirm that Jonathan..
Zotefoams Plc (LON:ZTF) CEO David Stirling talks to DirectorsTalk about its strong interim results for the six months ended 30 June 2018. David explains what has driven the growth, why..
Hastings Group Holdings plc (LON:HSTG), the technology driven insurance provider, today announced its interim results for the six months ended 30 June 2018. Hastings’ strong results and continued profitable growth..
Frontier IP Group Plc (LON:FIPP) Portfolio Manager Rui Andres talks to DirectorsTalk about the first Portuguese spin out developing novel technologies to print electronics onto paper. Rui discusses the significance..
Smurfit Kappa (LON:SKG) have received the Signify ‘Passion for Results’ award for outstanding customer support and service delivery. Supply chain optimisation and a reduction in costs, coupled with exemplary customer..
Glencore Plc (LON:GLEN), announced half year report for 2018. Highlights Glencore’s Chief Executive Officer, Ivan Glasenberg, commented: “The strength of our diversified business model and commodity mix is once again..
Paddy Power Betfair plc (LON:PPB) announced interim results for the six months ended 30 June 2018. £m H1 2018 £m H1 2017 £m YoY % Constant currency3 YoY % Revenue..
Motif Bio plc (LON:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, has today announced that the Company has received a Notice of Allowance from the United States Patent..
